{"id":"W3159897478","doi":"10.1016/j.jaad.2021.04.085","title":"Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: Results from 2 phase 3, randomized, double-blind studies","year":2021,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":297,"is_retracted":false,"has_abstract":false,"ca_institutions":"Probity Medical Research","funders":"Incyte; Intel Corporation","keywords":"Medicine; Atopic dermatitis; Ruxolitinib; Eczema Area and Severity Index; Clinical endpoint; Randomized controlled trial; Dermatology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002306083,0.0001767427,0.002113462,0.0001014657,0.00008313942,0.000002859795,0.0001944164,0.00009172074,0.00001059436],"category_scores_gemma":[0.001000201,0.00009134899,0.0005335539,0.0001794697,0.002119066,0.00005095113,0.00005490996,0.0001895864,3.540448e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002349726,"about_ca_system_score_gemma":0.0001730888,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001979569,"about_ca_topic_score_gemma":0.000002093836,"domain_scores_codex":[0.997485,0.0004474295,0.001522139,0.0001473827,0.0002122935,0.0001857742],"domain_scores_gemma":[0.991104,0.005930612,0.002409218,0.0002235934,0.0002423827,0.0000901674],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9303795,0.004606132,0.01216865,0.0005513922,0.01607828,0.0002338271,0.006125495,0.00004850192,0.001462454,0.001637813,0.01154715,0.01516077],"study_design_scores_gemma":[0.8532061,0.0006925902,0.02615532,0.0006212122,0.006455794,0.006115458,0.003480459,0.0001030393,0.08726152,0.001827098,0.01392496,0.0001564373],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9284139,0.03388197,0.00009260741,0.0366115,0.0001294867,0.0006367108,0.0001532038,0.000003855471,0.00007675251],"genre_scores_gemma":[0.9779113,0.02036793,0.000734903,0.0008320821,0.00008131649,0.00001667085,0.000007843514,0.00001053375,0.00003743853],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08579907,"threshold_uncertainty_score":0.7807788,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0536459511798173,"score_gpt":0.3889586485293915,"score_spread":0.3353126973495743,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}